Seeing Is Believing
with an average price target of $9.34. This is a potential upside of $5.45 (140.1%) from yesterday's end of day stock price of $3.89.
Vanda Pharmaceuticals's activity chart (see below) currently has 51 price targets and 30 ratings on display.
Analysts average stock forecasts to be materialized ratio is 79.89% with an average time for these price targets to be met of 454.5 days.
Most recent stock forecast was given by CHRIS HOWERTON from JEFFERIES on 25-Feb-2022. First documented stock forecast 17-Jan-2013.
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
12
$8.11 (208.48%)
24
2 years 1 months 3 days ago
2/4 (50%)
$0.82 (7.33%)
46
Hold
18
$14.11 (362.72%)
14
3 years 1 months 17 days ago
8/9 (88.89%)
$-0.67 (-3.59%)
235
Sell
7
$3.11 (79.95%)
12
4 years 12 days ago
4/4 (100%)
$-1.1 (-13.58%)
285
Buy
25
$20.66 (476.04%)
52
4 years 1 months 2 days ago
1/3 (33.33%)
$14.34 (78.91%)
446
Hold
17
$13.11 (337.02%)
26
4 years 8 months 3 days ago
4/6 (66.67%)
$4.73 (38.55%)
248
What is VNDA (Vanda Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on VNDA (Vanda Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on VNDA (Vanda Pharmaceuticals)?
Which analyst is the currently most bullish on VNDA (Vanda Pharmaceuticals)?
Which analyst is the currently most reserved on VNDA (Vanda Pharmaceuticals)?